Citigroup
ETON icon

Citigroup’s Eton Pharmaceutcials ETON Stock Holding History

Citigroup’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$758K Buy
20,952
+18,404
+722% +$540K ﹤0.01% 3646
2026
Q1 		$62.9K Buy
2,548
+1,097
+76% +$19.2K ﹤0.01% 4435
2025
Q4 		$24.5K Buy
1,451
+240
+20% +$4.22K ﹤0.01% 4811
2025
Q3 		$26.3K Sell
1,211
-7,892
-87% -$131K ﹤0.01% 4723
2025
Q2 		$130K Buy
9,103
+9,102
+910,200% +$144K ﹤0.01% 4294
2025
Q1 		$13 Sell
1
-21,976
-100% -$332K ﹤0.01% 5485
2024
Q4 		$293K Sell
21,977
-4,518
-17% -$45.8K ﹤0.01% 4162
2024
Q3 		$159K Buy
+26,495
New +$112K ﹤0.01% 4507
2024
Q1 		– Sell
-2,230
Closed -$9.77K – 5700
2023
Q4 		$9.77K Buy
+2,230
New +$8.94K ﹤0.01% 5201
2021
Q3 		– Sell
-810
Closed -$5K – 5905
2021
Q2 		$5K Sell
810
-932
-54% -$6.91K ﹤0.01% 5839
2021
Q1 		$13K Sell
1,742
-2,158
-55% -$18.4K ﹤0.01% 5477
2020
Q4 		$32K Buy
3,900
+2,580
+195% +$19.9K ﹤0.01% 6344
2020
Q3 		$10K Sell
1,320
-1,526
-54% -$10.4K ﹤0.01% 6609
2020
Q2 		$16K Buy
+2,846
New +$14.1K ﹤0.01% 6770

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Citigroup's ETON Position: Q2 2026 in Review

Citigroup increased its Eton Pharmaceutcials (ETON) stake by 722% in Q2 2026, buying an estimated $540K and bringing the position to 20,952 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #3646.

Citigroup first reported a position in ETON in Q2 2020 and has held it in 14 quarters since. 59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Citigroup held 20,952 shares of Eton Pharmaceutcials worth $758K as of Q2 2026.
  • Citigroup bought 18,404 Eton Pharmaceutcials shares in Q2 2026, an estimated $540K.
  • Eton Pharmaceutcials made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3646 holding.
  • Citigroup first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 14 quarters since.
  • 59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.